Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Clin Oncol ; 33(2): 125-7, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19675445

ABSTRACT

BACKGROUND: Microcystic adnexal carcinoma (MAC) is a very rare cancer of the skin. It has only been described previously in case reports and small retrospective series. OBJECTIVE: To analyze and summarize data from the National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) database regarding MAC. METHODS: The SEER 1973 to 2004 database was investigated, and patients with MAC were identified. A statistical analysis was performed. RESULTS: Two hundred twenty-three patients were identified. Predominant site of disease was the head and neck skin (74%). There was only 1 case of recorded metastatic disease. Lymph nodes were pathologically involved in 1%. The 10-year overall survival was 86.4% (Standard Error [SE]: 3.3%). US census population-matched relative survival was 97.7% at 10 years (SE: 5.2%). LIMITATIONS: This study is limited by the retrospective nature of the SEER database. CONCLUSIONS: MAC is locally invasive, and rarely metastasizes to lymph nodes. Overall and population-matched relative survival is excellent.


Subject(s)
Carcinoma, Ductal/pathology , Carcinoma, Skin Appendage/pathology , Skin Neoplasms/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Ductal/epidemiology , Carcinoma, Skin Appendage/epidemiology , Child , Female , Humans , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Middle Aged , Retrospective Studies , SEER Program , Skin Neoplasms/epidemiology , Survival Rate , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL